Barely Significant
← all phrases

“showed a trend”

53,323 sentences · 53,323 papers · 65,371 search hits before verification

In the literature

Following differentiation, the neurospheres cultured in the presence of 1 mM histamine showed a trend towards more neuronal lineage differentiation (control: 24.8 ± 4.2 vs 1 mM histamine: 29.7 ± 5.3% β-III-tubulin + neurons), whereas the neurospheres grown in the presence of both chlorpheniramine and cimetidine generated significantly fewer neurons upon differentiation (chlorpheniramine: 6.7 ± 2.2 and cimetidine: 8.6 ± 2.2% β-III-tubulin + neurons, p < 0.05; Fig. 6C ).
There were no group effects or time x group interaction ( P values >.1) on distress tolerance (breath-holding time), although participants showed a trend toward longer breath-holding times after (i.e., at the behavior 2 time point) compared with before strategy instructions (behavior 1 time point; F(1,64) = 3.911, P =.052; Table 2 ).
Hemolymph osmolality, ionic concentrations, and free amino acid composition Hemolymph osmolality showed a trend of decrease initially (a minimum detected at 6‰) but subsequently increased as salinity increased from 0 to 18‰, however no significant difference was detected among all treatments ( P < 0.05, Figure 4A ).
In conclusion, in comparison with the 30-Gy regimen, the dose-escalation regimen with conventionally-fractionated IG-IMRT showed a trend of achieving better dosimetric parameters, increasing pain relief and potentially improving the quality of life for patients with spinal metastases, and thus being recommended for these patients, especially those with a long life expectancy.
40 , 41 , 42 , 43 , 44 Among older adults, CT using Lumosity showed a trend toward improving executive control and other domains of cognition. 41 In addition, with a 6-month ET intervention, older adults without ET had a decline in cognitive function, whereas those patients with ET had preserved cognitive function over 18 months. 42 This study extended these findings of the cognitive decline of aging to the cognitive decline associated with ESRD and HD, and to adults of all ages.
A recent published meta-analysis, which collected studies from 1990 to 2012, showed a trend toward survival benefits of systemic corticosteroids compared to supportive care (odds ratio: 0.54; 95% CI: 0.29–1.01) and suggested that systemic corticosteroids are one of the most promising immunomodulating therapies for SJS/TEN [ 38 ].
Treatments for Severe Cutaneous Adverse Reactions.
J Immunol Res · 2017 · PMC5763067